Looking for additional ways to earn continuing medical education credit? Take advantage of the following opportunities to satisfy your AOA-sponsored CME requirements and increase your knowledge about recent developments in osteopathic medicine.
On-Demand CME Web Activities
Program Description:
More than 60% of diabetes mellitus (DM) patients do not reach HbA1c target goals. Advances in the understanding of glucose homeostasis have helped identify new therapeutic targets, such as incretin hormones, which may address some of the unmet needs of conventional type 2 diabetes medications. These agents are associated with a low risk of unwanted adverse events and offer physicians additional options to deliver individualized care. DM management recommendations are being updated regularly, and guidelines are a helpful starting point for physicians, providing them with evidence-based treatment options. However, treatments should be individualized to each patient, and DOs need all the latest information and up-to-date data in order to deliver such individualized care. This monograph is approved for 1.0 credit of AOA Category 1-B. View the monograph now.
No Sugar Coating Required: Real-Life Application of Incretin-Based Therapies in Type 2 Diabetes
Program Description
Incretin-based therapies, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase-4 (DPP-4) inhibitors, provide effective glycemic control in type 2 diabetes (T2D), paired with beneficial nonglycemic effects on weight, lipids, and blood pressure. Additionally, these agents can be used in a wide variety of patients.
This unique program will highlight the comparative effectiveness and safety of these agents, appropriate patient selection, timely treatment initiation, and common barriers to glycemic control through the use of a simulated patient. The faculty will interview the patient, replicating an actual office visit. Supporting evidence will be presented to address the clinical concerns raised in the patient interview. At the conclusion of each talk, the faculty panel will discuss the case and offer clinical pearls and interviewing approaches to overcome patient-related barriers.
The AOA has approved this activity for for 2.5 hours of AOA Category 1-B credit. It will expire on Dec. 31, 2012, and it takes approximately 2.5 hours to complete. View the activity now.
Comparative Effectiveness Research from the AHRQ
Program Description:
The American Osteopathic Association (AOA) is pleased to announce a new partnership with the Agency for Healthcare Research and Quality (AHRQ). AHRQ’s CME programs on Comparative Effectiveness Research (CER) are now available to osteopathic physicians nationwide.
The free, online courses address a variety of therapeutic and disease areas encountered in every day practice. They are eligible for AOA Category 2-B credit. There will be about 40 hours of CME credits offered by September 2012. View the course now.